The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-05-26

AUTHORS

Tetsushi Nakao, Takeshi Kimura, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Masakiyo Nobuyoshi, Toru Kita, Kazuaki Mitsudo

ABSTRACT

Several clinical studies have reported the use of cilostazol in addition to aspirin and thienopyridine (triple antiplatelet therapy, TAPT) after percutaneous coronary intervention (PCI) decreases clinical events. However, the efficacy and safety of TAPT have not been fully evaluated in Japan. The prospectively collected data from 12824 Japanese patients received PCI as part of the j-Cypher Registry were analyzed. We selected 10356 patients who exclusively received implantation of sirolimus-eluting stents (SES), and compared the data from 10128 patients who received dual antiplatelet therapy (aspirin + thienopyridine, DAPT) with 228 patients who received TAPT at the time of discharge. Patients who received TAPT had more comorbidities, such as peripheral vascular disease, renal failure with hemodialysis or insulin dependent diabetes mellitus, and more patients received stenting for the left main trunk. The cardiovascular event rates at 3 years after PCI in the TAPT group were not significantly different from DAPT group, even after adjusted risks for cardiovascular events; all-cause death (7.8 vs. 6.7 %, log-rank p = 0.44, adjusted Hazard Ratio [HR] 0.88: 95 % confidence interval [CI] 0.52–1.38, p = 0.61), myocardial infarction (1.7 vs. 2.4 %, log-rank p = 0.49 and HR 0.71: 95 % CI 0.20–1.57, p = 0.40), target legion revascularization (12.7 vs. 9.9 %, log-rank p = 0.11 and HR 1.05: 95 % CI 0.71–1.50, p = 0.91) and stroke (3.9 vs. 3.2 %, log-rank p = 0.52 and HR 1.09: 95 % CI 0.52–2.00, p = 0.80). In conclusion, TAPT after SES implantation was associated with similar long-term clinical outcomes as DAPT in Japanese real-world clinical practice, although we did not evaluate the bleeding outcome. More... »

PAGES

161-167

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12928-012-0105-4

DOI

http://dx.doi.org/10.1007/s12928-012-0105-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041191035

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22638734


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asians", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cilostazol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakao", 
        "givenName": "Tetsushi", 
        "id": "sg:person.01225736750.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225736750.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Takeshi", 
        "id": "sg:person.012173163322.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012173163322.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Medical Education and Clinical Epidemiology Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Center for Medical Education and Clinical Epidemiology Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morimoto", 
        "givenName": "Takeshi", 
        "id": "sg:person.011273662612.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273662612.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410843.a", 
          "name": [
            "Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furukawa", 
        "givenName": "Yutaka", 
        "id": "sg:person.01125356072.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125356072.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Tenri Hospital, Tenri, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416952.d", 
          "name": [
            "Division of Cardiology, Tenri Hospital, Tenri, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakagawa", 
        "givenName": "Yoshihisa", 
        "id": "sg:person.01055776641.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055776641.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415565.6", 
          "name": [
            "Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kadota", 
        "givenName": "Kazushige", 
        "id": "sg:person.014665411723.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014665411723.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Kokura Memorial Hospital, Kokura, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Division of Cardiology, Kokura Memorial Hospital, Kokura, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nobuyoshi", 
        "givenName": "Masakiyo", 
        "id": "sg:person.01275721512.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275721512.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kita", 
        "givenName": "Toru", 
        "id": "sg:person.01016114776.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016114776.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415565.6", 
          "name": [
            "Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitsudo", 
        "givenName": "Kazuaki", 
        "id": "sg:person.0612733711.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612733711.29"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2012-05-26", 
    "datePublishedReg": "2012-05-26", 
    "description": "Several clinical studies have reported the use of cilostazol in addition to aspirin and thienopyridine (triple antiplatelet therapy, TAPT) after percutaneous coronary intervention (PCI) decreases clinical events. However, the efficacy and safety of TAPT have not been fully evaluated in Japan. The prospectively collected data from 12824 Japanese patients received PCI as part of the j-Cypher Registry were analyzed. We selected 10356 patients who exclusively received implantation of sirolimus-eluting stents (SES), and compared the data from 10128 patients who received dual antiplatelet therapy (aspirin\u00a0+\u00a0thienopyridine, DAPT) with 228 patients who received TAPT at the time of discharge. Patients who received TAPT had more comorbidities, such as peripheral vascular disease, renal failure with hemodialysis or insulin dependent diabetes mellitus, and more patients received stenting for the left main trunk. The cardiovascular event rates at 3\u00a0years after PCI in the TAPT group were not significantly different from DAPT group, even after adjusted risks for cardiovascular events; all-cause death (7.8 vs. 6.7\u00a0%, log-rank p\u00a0=\u00a00.44, adjusted Hazard Ratio [HR] 0.88: 95\u00a0% confidence interval [CI] 0.52\u20131.38, p\u00a0=\u00a00.61), myocardial infarction (1.7 vs. 2.4\u00a0%, log-rank p\u00a0=\u00a00.49 and HR 0.71: 95\u00a0% CI 0.20\u20131.57, p\u00a0=\u00a00.40), target legion revascularization (12.7 vs. 9.9\u00a0%, log-rank p\u00a0=\u00a00.11 and HR 1.05: 95\u00a0% CI 0.71\u20131.50, p\u00a0=\u00a00.91) and stroke (3.9 vs. 3.2\u00a0%, log-rank p\u00a0=\u00a00.52 and HR 1.09: 95\u00a0% CI 0.52\u20132.00, p\u00a0=\u00a00.80). In conclusion, TAPT after SES implantation was associated with similar long-term clinical outcomes as DAPT in Japanese real-world clinical practice, although we did not evaluate the bleeding outcome.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12928-012-0105-4", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6037607", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6066536", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1042779", 
        "issn": [
          "1868-4300", 
          "1868-4297"
        ], 
        "name": "Cardiovascular Intervention and Therapeutics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "percutaneous coronary intervention", 
      "j-Cypher registry", 
      "dual antiplatelet therapy", 
      "sirolimus-eluting stents", 
      "antiplatelet therapy", 
      "Japanese patients", 
      "similar long-term clinical outcomes", 
      "Japanese real-world clinical practice", 
      "long-term clinical outcomes", 
      "sirolimus-eluting stent implantation", 
      "insulin-dependent diabetes mellitus", 
      "real-world clinical practice", 
      "use of cilostazol", 
      "left main trunk", 
      "peripheral vascular disease", 
      "cardiovascular event rates", 
      "dependent diabetes mellitus", 
      "time of discharge", 
      "long-term efficacy", 
      "more comorbidities", 
      "TAPT group", 
      "cause death", 
      "DAPT group", 
      "cardiovascular events", 
      "SES implantation", 
      "coronary intervention", 
      "renal failure", 
      "diabetes mellitus", 
      "more patients", 
      "clinical outcomes", 
      "clinical events", 
      "stent implantation", 
      "vascular disease", 
      "myocardial infarction", 
      "clinical studies", 
      "patients", 
      "clinical practice", 
      "event rates", 
      "main trunk", 
      "cilostazol", 
      "registry", 
      "therapy", 
      "outcomes", 
      "implantation", 
      "efficacy", 
      "TAPT", 
      "revascularization", 
      "comorbidities", 
      "mellitus", 
      "hemodialysis", 
      "infarction", 
      "aspirin", 
      "group", 
      "thienopyridines", 
      "follow", 
      "stroke", 
      "stents", 
      "disease", 
      "DAPT", 
      "death", 
      "intervention", 
      "risk", 
      "trunk", 
      "conclusion", 
      "events", 
      "safety", 
      "failure", 
      "years", 
      "data", 
      "addition", 
      "discharge", 
      "study", 
      "rate", 
      "use", 
      "practice", 
      "time", 
      "Japan", 
      "analysis", 
      "part"
    ], 
    "name": "The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry", 
    "pagination": "161-167", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041191035"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12928-012-0105-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22638734"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12928-012-0105-4", 
      "https://app.dimensions.ai/details/publication/pub.1041191035"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_579.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12928-012-0105-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12928-012-0105-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12928-012-0105-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12928-012-0105-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12928-012-0105-4'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      20 PREDICATES      120 URIs      112 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12928-012-0105-4 schema:about N0fcc082e68fb45ed9ec7b9c128edafb9
2 N2898dc3e817b43aab5c5d53af0f1c77b
3 N2b65a387f3834f959409026c95439841
4 N307bdde8f55a4fa28f20aff761e3120b
5 N3d2a7ffd679c42d79c765c59849b9f64
6 N45eea0f01472485aa948e24a78bec650
7 N4a2243326eaa4d0b8696062bed908ea1
8 N4eaae8c8b7c44963b8687c0191a2ee0f
9 N65dcb74c30a94f109d02aaced43bac77
10 N892b4b44199c49f49dd4350364c57622
11 Naf89bde5eb82442db3d7fabd47b45f40
12 Ncb3986e6d76b49e7be2ac28a8e245dd3
13 Nd32cf61349ae4edc8a17cdbc31993d9d
14 Ndd01d60026344bffa4372be13b347de1
15 Nf2e24bda3ea54c12b209b437cc4d7dc4
16 Nfce35e028d914201a7351b8c187f4653
17 anzsrc-for:11
18 anzsrc-for:1102
19 schema:author Nb4fb19bc89c3440ea9eb0eb2c8490cee
20 schema:datePublished 2012-05-26
21 schema:datePublishedReg 2012-05-26
22 schema:description Several clinical studies have reported the use of cilostazol in addition to aspirin and thienopyridine (triple antiplatelet therapy, TAPT) after percutaneous coronary intervention (PCI) decreases clinical events. However, the efficacy and safety of TAPT have not been fully evaluated in Japan. The prospectively collected data from 12824 Japanese patients received PCI as part of the j-Cypher Registry were analyzed. We selected 10356 patients who exclusively received implantation of sirolimus-eluting stents (SES), and compared the data from 10128 patients who received dual antiplatelet therapy (aspirin + thienopyridine, DAPT) with 228 patients who received TAPT at the time of discharge. Patients who received TAPT had more comorbidities, such as peripheral vascular disease, renal failure with hemodialysis or insulin dependent diabetes mellitus, and more patients received stenting for the left main trunk. The cardiovascular event rates at 3 years after PCI in the TAPT group were not significantly different from DAPT group, even after adjusted risks for cardiovascular events; all-cause death (7.8 vs. 6.7 %, log-rank p = 0.44, adjusted Hazard Ratio [HR] 0.88: 95 % confidence interval [CI] 0.52–1.38, p = 0.61), myocardial infarction (1.7 vs. 2.4 %, log-rank p = 0.49 and HR 0.71: 95 % CI 0.20–1.57, p = 0.40), target legion revascularization (12.7 vs. 9.9 %, log-rank p = 0.11 and HR 1.05: 95 % CI 0.71–1.50, p = 0.91) and stroke (3.9 vs. 3.2 %, log-rank p = 0.52 and HR 1.09: 95 % CI 0.52–2.00, p = 0.80). In conclusion, TAPT after SES implantation was associated with similar long-term clinical outcomes as DAPT in Japanese real-world clinical practice, although we did not evaluate the bleeding outcome.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N3359aaa02f834cf095d6936ce36b519e
26 N44b91b98f11848ecb5bf34d76f6f65cd
27 sg:journal.1042779
28 schema:keywords DAPT
29 DAPT group
30 Japan
31 Japanese patients
32 Japanese real-world clinical practice
33 SES implantation
34 TAPT
35 TAPT group
36 addition
37 analysis
38 antiplatelet therapy
39 aspirin
40 cardiovascular event rates
41 cardiovascular events
42 cause death
43 cilostazol
44 clinical events
45 clinical outcomes
46 clinical practice
47 clinical studies
48 comorbidities
49 conclusion
50 coronary intervention
51 data
52 death
53 dependent diabetes mellitus
54 diabetes mellitus
55 discharge
56 disease
57 dual antiplatelet therapy
58 efficacy
59 event rates
60 events
61 failure
62 follow
63 group
64 hemodialysis
65 implantation
66 infarction
67 insulin-dependent diabetes mellitus
68 intervention
69 j-Cypher registry
70 left main trunk
71 long-term clinical outcomes
72 long-term efficacy
73 main trunk
74 mellitus
75 more comorbidities
76 more patients
77 myocardial infarction
78 outcomes
79 part
80 patients
81 percutaneous coronary intervention
82 peripheral vascular disease
83 practice
84 rate
85 real-world clinical practice
86 registry
87 renal failure
88 revascularization
89 risk
90 safety
91 similar long-term clinical outcomes
92 sirolimus-eluting stent implantation
93 sirolimus-eluting stents
94 stent implantation
95 stents
96 stroke
97 study
98 therapy
99 thienopyridines
100 time
101 time of discharge
102 trunk
103 use
104 use of cilostazol
105 vascular disease
106 years
107 schema:name The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry
108 schema:pagination 161-167
109 schema:productId N2dc9f406b3724a20a05df6b0460e4649
110 N4c447cee1cdd4c5595817827de0bc98c
111 Nea69abb384a640d39c6fad2d87d41387
112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041191035
113 https://doi.org/10.1007/s12928-012-0105-4
114 schema:sdDatePublished 2022-09-02T15:55
115 schema:sdLicense https://scigraph.springernature.com/explorer/license/
116 schema:sdPublisher N5bfda3b1697a433895bb121495a49469
117 schema:url https://doi.org/10.1007/s12928-012-0105-4
118 sgo:license sg:explorer/license/
119 sgo:sdDataset articles
120 rdf:type schema:ScholarlyArticle
121 N0fcc082e68fb45ed9ec7b9c128edafb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Sirolimus
123 rdf:type schema:DefinedTerm
124 N14873fbd97e745bd9a90ce5fd108c3af rdf:first sg:person.012173163322.36
125 rdf:rest N4266e998938348088ea42931489337b8
126 N1c8b6e15a1ce41268ba1c72091000093 rdf:first sg:person.014665411723.19
127 rdf:rest N5b021bee67754ca2ad22f70f8aacdca0
128 N2898dc3e817b43aab5c5d53af0f1c77b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Platelet Aggregation Inhibitors
130 rdf:type schema:DefinedTerm
131 N2b65a387f3834f959409026c95439841 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Asians
133 rdf:type schema:DefinedTerm
134 N2dc9f406b3724a20a05df6b0460e4649 schema:name pubmed_id
135 schema:value 22638734
136 rdf:type schema:PropertyValue
137 N307bdde8f55a4fa28f20aff761e3120b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Humans
139 rdf:type schema:DefinedTerm
140 N31480268a4e64c0d810929b900c511d8 rdf:first sg:person.01055776641.19
141 rdf:rest N1c8b6e15a1ce41268ba1c72091000093
142 N3359aaa02f834cf095d6936ce36b519e schema:issueNumber 3
143 rdf:type schema:PublicationIssue
144 N3d2a7ffd679c42d79c765c59849b9f64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Male
146 rdf:type schema:DefinedTerm
147 N4266e998938348088ea42931489337b8 rdf:first sg:person.011273662612.03
148 rdf:rest N5c31a6e1696f4c9db4722d850635be15
149 N44b91b98f11848ecb5bf34d76f6f65cd schema:volumeNumber 27
150 rdf:type schema:PublicationVolume
151 N45eea0f01472485aa948e24a78bec650 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Survival Rate
153 rdf:type schema:DefinedTerm
154 N4a2243326eaa4d0b8696062bed908ea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Tetrazoles
156 rdf:type schema:DefinedTerm
157 N4c447cee1cdd4c5595817827de0bc98c schema:name doi
158 schema:value 10.1007/s12928-012-0105-4
159 rdf:type schema:PropertyValue
160 N4eaae8c8b7c44963b8687c0191a2ee0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Percutaneous Coronary Intervention
162 rdf:type schema:DefinedTerm
163 N5b021bee67754ca2ad22f70f8aacdca0 rdf:first sg:person.01275721512.32
164 rdf:rest Nd6a75077a86848538505d97b5c9c7403
165 N5bfda3b1697a433895bb121495a49469 schema:name Springer Nature - SN SciGraph project
166 rdf:type schema:Organization
167 N5c31a6e1696f4c9db4722d850635be15 rdf:first sg:person.01125356072.66
168 rdf:rest N31480268a4e64c0d810929b900c511d8
169 N65dcb74c30a94f109d02aaced43bac77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Treatment Outcome
171 rdf:type schema:DefinedTerm
172 N892b4b44199c49f49dd4350364c57622 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Cilostazol
174 rdf:type schema:DefinedTerm
175 Naf89bde5eb82442db3d7fabd47b45f40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Aged
177 rdf:type schema:DefinedTerm
178 Nb4fb19bc89c3440ea9eb0eb2c8490cee rdf:first sg:person.01225736750.47
179 rdf:rest N14873fbd97e745bd9a90ce5fd108c3af
180 Nba1a037852da40ca9caae9be2950c817 rdf:first sg:person.0612733711.29
181 rdf:rest rdf:nil
182 Ncb3986e6d76b49e7be2ac28a8e245dd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Registries
184 rdf:type schema:DefinedTerm
185 Nd32cf61349ae4edc8a17cdbc31993d9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Female
187 rdf:type schema:DefinedTerm
188 Nd6a75077a86848538505d97b5c9c7403 rdf:first sg:person.01016114776.36
189 rdf:rest Nba1a037852da40ca9caae9be2950c817
190 Ndd01d60026344bffa4372be13b347de1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Drug-Eluting Stents
192 rdf:type schema:DefinedTerm
193 Nea69abb384a640d39c6fad2d87d41387 schema:name dimensions_id
194 schema:value pub.1041191035
195 rdf:type schema:PropertyValue
196 Nf2e24bda3ea54c12b209b437cc4d7dc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Aged, 80 and over
198 rdf:type schema:DefinedTerm
199 Nfce35e028d914201a7351b8c187f4653 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Follow-Up Studies
201 rdf:type schema:DefinedTerm
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
206 schema:name Cardiorespiratory Medicine and Haematology
207 rdf:type schema:DefinedTerm
208 sg:grant.6037607 http://pending.schema.org/fundedItem sg:pub.10.1007/s12928-012-0105-4
209 rdf:type schema:MonetaryGrant
210 sg:grant.6066536 http://pending.schema.org/fundedItem sg:pub.10.1007/s12928-012-0105-4
211 rdf:type schema:MonetaryGrant
212 sg:journal.1042779 schema:issn 1868-4297
213 1868-4300
214 schema:name Cardiovascular Intervention and Therapeutics
215 schema:publisher Springer Nature
216 rdf:type schema:Periodical
217 sg:person.01016114776.36 schema:affiliation grid-institutes:grid.258799.8
218 schema:familyName Kita
219 schema:givenName Toru
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016114776.36
221 rdf:type schema:Person
222 sg:person.01055776641.19 schema:affiliation grid-institutes:grid.416952.d
223 schema:familyName Nakagawa
224 schema:givenName Yoshihisa
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055776641.19
226 rdf:type schema:Person
227 sg:person.01125356072.66 schema:affiliation grid-institutes:grid.410843.a
228 schema:familyName Furukawa
229 schema:givenName Yutaka
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125356072.66
231 rdf:type schema:Person
232 sg:person.011273662612.03 schema:affiliation grid-institutes:grid.258799.8
233 schema:familyName Morimoto
234 schema:givenName Takeshi
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273662612.03
236 rdf:type schema:Person
237 sg:person.012173163322.36 schema:affiliation grid-institutes:grid.258799.8
238 schema:familyName Kimura
239 schema:givenName Takeshi
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012173163322.36
241 rdf:type schema:Person
242 sg:person.01225736750.47 schema:affiliation grid-institutes:grid.258799.8
243 schema:familyName Nakao
244 schema:givenName Tetsushi
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225736750.47
246 rdf:type schema:Person
247 sg:person.01275721512.32 schema:affiliation grid-institutes:grid.415432.5
248 schema:familyName Nobuyoshi
249 schema:givenName Masakiyo
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275721512.32
251 rdf:type schema:Person
252 sg:person.014665411723.19 schema:affiliation grid-institutes:grid.415565.6
253 schema:familyName Kadota
254 schema:givenName Kazushige
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014665411723.19
256 rdf:type schema:Person
257 sg:person.0612733711.29 schema:affiliation grid-institutes:grid.415565.6
258 schema:familyName Mitsudo
259 schema:givenName Kazuaki
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612733711.29
261 rdf:type schema:Person
262 grid-institutes:grid.258799.8 schema:alternateName Center for Medical Education and Clinical Epidemiology Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan
263 Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan
264 schema:name Center for Medical Education and Clinical Epidemiology Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan
265 Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan
266 rdf:type schema:Organization
267 grid-institutes:grid.410843.a schema:alternateName Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
268 schema:name Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
269 rdf:type schema:Organization
270 grid-institutes:grid.415432.5 schema:alternateName Division of Cardiology, Kokura Memorial Hospital, Kokura, Japan
271 schema:name Division of Cardiology, Kokura Memorial Hospital, Kokura, Japan
272 rdf:type schema:Organization
273 grid-institutes:grid.415565.6 schema:alternateName Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan
274 schema:name Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan
275 rdf:type schema:Organization
276 grid-institutes:grid.416952.d schema:alternateName Division of Cardiology, Tenri Hospital, Tenri, Japan
277 schema:name Division of Cardiology, Tenri Hospital, Tenri, Japan
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...